Articles

My wife is older, but receives less Social Security than I do. Can she switch to spousal benefits?

“I’m 60 and my wife is 62. She has already filed for her Social Security.”

Here’s how much worse the global oil supply could get due to the U.S. blockade in Iran

The U.S. blockade of Iranian ports could accelerate the drawdown in global oil inventories, further tightening near-term supply and pushing back hopes of market normalization into mid-May, according to Société Générale.

These 20 stocks in the now-cheap tech sector are positioned for the fastest growth through 2028

The S&P 500 information-technology sector’s forward P/E ratio is at its lowest relative to five-year averages among all sectors in the index.

You can negotiate with colleges to pay less. Here’s how I did it.

Every dollar you don’t need to borrow for higher education is worth the effort, even if asking for a discount feels uncomfortable

Wells Fargo sees little change in guidance despite spike in oil prices

The fourth-largest lender in the U.S. said its outlook for net interest income and noninterest expense in 2026 has remained unchanged

‘It is their fault’: My condo board forgot to bill for storage fees. Must I pay retroactively?

“They now intend to bill us for seven to eight months of storage fees.”

JPMorgan’s markets and investment banking revenue surge, but here’s why the stock is pulling back

JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.

Fund-manager pessimism builds but not at ‘close-your-eyes-and-buy’ levels, says Bank of America

The April FMS was eagerly awaited given the oil price shock caused by events in the Middle East. While sentiment darkened, though, investors seem reluctant to cut risk significantly.

Why two Wall Street titans just turned bullish on U.S. stocks

Citigroup and BlackRock Investment Institute have both turned bullish on U.S. stocks. They say tech dominance is a part of that.

J&J raises guidance for 2026 on strong start to the year

Johnson & Johnson said its pharmaceutical sales rose 11.2% in the first quarter of 2026.

Space investing is heating up as SpaceX rockets toward a record-breaking IPO

Hype around Elon Musk, a major moon mission and space-based data centers is driving interest in the sector.

Fink hails one of BlackRock’s ‘strongest starts to a year in our history’

The world’s biggest asset manager beat earnings forecasts after a surge into its exchange-traded funds
1 183 184 185 186 187 2,702